Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Whole genome sequence of actinomycetes

PROVIDER: PRJNA1190622 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR31511060.fastq.gz	Fastqsanger.gz
	SRR31511061.fastq.gz	Fastqsanger.gz
	SRR31511062.fastq.gz	Fastqsanger.gz
	SRR31511063.fastq.gz	Fastqsanger.gz
	SRR31511064.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 9

Similar Datasets

QTOF HRMS data for Actinomycetes strains whole-genome-sequenced on Oxford Nanopore Flongle.

Project description:This is an HRMS dataset from Actinomycetes strains cultures that were also whole-genome-sequenced.

2021-08-06 | MSV000087950 | MassIVE

Project description:Whole genome sequences of Actinomycetes

| PRJNA690886 | ENA

Project description:actinomycetes sequence

| PRJNA659898 | ENA

Project description:Whole-genome sequences of Actinomycetes in Thailand

| PRJNA758547 | ENA

Project description:Whole genome sequences of Actinomycetes isolated from Thailand

| PRJNA613987 | ENA

Project description:Whole-genome sequences of marine actinomycetes in Thailand

| PRJNA888249 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Total protein of S. aureus treated and untreated with Streptomyces sp. GKU 223

Project description:This study is aimed to isolate marine actinomycetes from sediments from Andaman and the Gulf of Thailand. All 101 marine actinomycetes were screened for anti-biofilm activity. Streptomyces sp. GKU223 showed significantly inhibited biofilm formation of S. aureus. The evaluation of supernatants of anti-biofilm activity produced by Streptomyces sp. GKU223 has been performed. Since the interaction between marine actinomycetes and biofilm forming bacteria has never been investigated, proteomic analysis has been used to identify whole cell proteins involved in anti–biofilm activity. Understanding the interaction at molecular level will lead to sustainably use for anti-biofilm producing marine actinomycetes in pharmaceutical and medicinal applications in the future.

2018-08-20 | PXD010815 | JPOST Repository

Analysis of the dose-dependent response of the ribosome-targeting antibiotic lincomycin on gene expression and its relationship to growth and secondary metabolism of S. coelicolor A3(2).

Project description:Lincomycin is a lincosamide antibiotic that forms cross-links within the peptidyl transferase loop region of the 23S rRNA of the 50S subunit of the bacterial ribosome, thereby inhibiting protein synthesis. We have previously reported that lincomycin at concentrations below the minimum inhibitory concentration potentiates the production of secondary metabolites in actinomycete strains. We aimed to elucidate the fundamental mechanisms underlying lincomycin induction of secondary metabolism in actinomycetes. Therefore, the dose-dependent response of lincomycin on gene expression of the model actinomycetes Streptomyces coelicolor A3(2) and possible relationships to secondary metabolism have been investigated.

2018-03-02 | E-MTAB-6434 | biostudies-arrayexpress

Analysis of Escherichia coli treated and untreated with Streptomyces sp. GKU 257-1

Project description:This study is aimed to isolate marine actinomycetes from sediments from Andaman and the Gulf of Thailand. All 101 marine actinomycetes were screened for anti-biofilm activity. Streptomyces sp. GKU 257-1 showed significantly inhibited biofilm formation of E. coli. The evaluation of supernatants of anti-biofilm activity produced by Streptomyces sp. GKU 257-1 has been performed. Since the interaction between marine actinomycetes and biofilm forming bacteria has never been investigated, proteomic analysis has been used to identify whole cell proteins involved in anti–biofilm activity. Understanding the interaction at molecular level will lead to sustainably use for anti-biofilm producing marine actinomycetes in pharmaceutical and medicinal applications in the future.

2019-09-07 | PXD011027 | JPOST Repository

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data